Literature DB >> 27370636

Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.

L I Velikanova1, Z R Shafigullina2, A A Lisitsin2, N V Vorokhobina2, K Grigoryan2, E A Kukhianidze2, E G Strelnikova2, N S Krivokhizhina2, L M Krasnov3, E A Fedorov3, I V Sablin3, A L Moskvin4, E A Bessonova4.   

Abstract

Urinary steroid profiling (USP) was studied using high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) methods in 108 patients with adrenocortical adenoma (ACA) and in 31 patients with adrenocortical carcinoma (ACC). Thirteen ACC and Cushing's syndrome (ACC-CS) patients had two types of USP as well as 18 ACC patients without hypercortisolism. These four types differed by androgen and glucocorticoid secretion of the adrenal cortex. Fifteen main ACC features were observed by GC-MS. Urinary excretion of dehydroepiandrosterone (DHEA) was increased in 67.7 % of ACC patients and tetrahydro-11-deoxycortisol (THS) in 74.2 %. By combination of the following parameters: THS >900 μg/24 h and/or DHEA >1500 μg/24 h with ratios of 3α,16,20-pregnentriol/3β,16,20-pregnentriol (3α,16,20dP3/3β,16,20dP3) less than 6.0 and 3α,17,20dP3/3β,17,20dP3 less than 9.0 and the detection of "non-classical" 5-en-pregnens, not found in ACA and healthy persons, 100 % sensitivity and specificity of ACC and ACA differential diagnosis were achieved. Features of 21-hydroxylase and 11β-hydroxylase deficiency were observed by GC-MS in 32.2 and 61.3 % of the ACC patients, respectively. Additional features for ACC-CS diagnostic were increased urinary excretion of 6β-hydroxycortisol, 18-hydroxycorticosterone, the sum (UFF + UFE) obtained by HPLC, tetrahydrocorticosterone, and the sum (THF + THE + allo-THF) obtained by GC-MS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27370636     DOI: 10.1007/s12672-016-0267-0

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  13 in total

1.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

2.  The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses.

Authors:  M Terzolo; A Alì; G Osella; G Reimondo; A Pia; P Peretti; P Paccotti; A Angeli
Journal:  Eur J Endocrinol       Date:  2000-06       Impact factor: 6.664

Review 3.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

Review 4.  Approach to the patient with an adrenal incidentaloma.

Authors:  Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

Review 5.  Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseases.

Authors:  Jeffrey G McDonald; Susan Matthew; Richard J Auchus
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

6.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

7.  Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.

Authors:  Amir H Hamrahian; Adriana G Ioachimescu; Erick M Remer; Gaspar Motta-Ramirez; Hari Bogabathina; Howard S Levin; Sethu Reddy; Inderbir S Gill; Allan Siperstein; Emmanuel L Bravo
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

Review 8.  [German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment].

Authors:  J Reibetanz; M Kroiss; T Deutschbein; W Fenske; M Gasser; C Jurowich; C-T Germer; B Allolio; M Fassnacht
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

9.  Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.

Authors:  Martin Fassnacht; Sarah Johanssen; Marcus Quinkler; Peter Bucsky; Holger S Willenberg; Felix Beuschlein; Massimo Terzolo; Hans-Helge Mueller; Stefanie Hahner; Bruno Allolio
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

10.  Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.

Authors:  Wiebke Arlt; Michael Biehl; Angela E Taylor; Stefanie Hahner; Rossella Libé; Beverly A Hughes; Petra Schneider; David J Smith; Han Stiekema; Nils Krone; Emilio Porfiri; Giuseppe Opocher; Jerôme Bertherat; Franco Mantero; Bruno Allolio; Massimo Terzolo; Peter Nightingale; Cedric H L Shackleton; Xavier Bertagna; Martin Fassnacht; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

View more
  13 in total

1.  Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia.

Authors:  Fady Hannah-Shmouni; Annabel Berthon; Fabio R Faucz; Juan Medina Briceno; Andrea Gutierrez Maria; Andrew Demidowich; Mirko Peitzsch; Jimmy Masjkur; Fidéline Bonnet-Serrano; Anna Vaczlavik; Jérôme Bertherat; Martin Reincke; Graeme Eisenhofer; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-07       Impact factor: 5.678

Review 2.  Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review.

Authors:  Marta Araujo-Castro; Pablo Valderrábano; Héctor F Escobar-Morreale; Felicia A Hanzu; Gregori Casals
Journal:  Endocrine       Date:  2020-11-21       Impact factor: 3.633

3.  Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.

Authors:  Nadia Gagnon; Pascale Boily; Catherine Alguire; Gilles Corbeil; Irina Bancos; Mathieu Latour; Catherine Beauregard; Katia Caceres; Zaki El Haffaf; Fred Saad; Harold J Olney; Isabelle Bourdeau
Journal:  Endocrine       Date:  2020-02-22       Impact factor: 3.633

Review 4.  Novel methods in adrenal research: a metabolomics approach.

Authors:  Thomas G Papathomas; Na Sun; Vasileios Chortis; Angela E Taylor; Wiebke Arlt; Susan Richter; Graeme Eisenhofer; Gerard Ruiz-Babot; Leonardo Guasti; Axel Karl Walch
Journal:  Histochem Cell Biol       Date:  2019-02-06       Impact factor: 4.304

5.  Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass.

Authors:  N F Lenders; J R Greenfield
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-11-28

6.  Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism.

Authors:  Karl-Heinz Storbeck; Lina Schiffer; Elizabeth S Baranowski; Vasileios Chortis; Alessandro Prete; Lise Barnard; Lorna C Gilligan; Angela E Taylor; Jan Idkowiak; Wiebke Arlt; Cedric H L Shackleton
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

7.  Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.

Authors:  Irina Bancos; Angela E Taylor; Vasileios Chortis; Alice J Sitch; Carl Jenkinson; Caroline J Davidge-Pitts; Katharina Lang; Stylianos Tsagarakis; Magdalena Macech; Anna Riester; Timo Deutschbein; Ivana D Pupovac; Tina Kienitz; Alessandro Prete; Thomas G Papathomas; Lorna C Gilligan; Cristian Bancos; Giuseppe Reimondo; Magalie Haissaguerre; Ljiljana Marina; Marianne A Grytaas; Ahmed Sajwani; Katharina Langton; Hannah E Ivison; Cedric H L Shackleton; Dana Erickson; Miriam Asia; Sotiria Palimeri; Agnieszka Kondracka; Ariadni Spyroglou; Cristina L Ronchi; Bojana Simunov; Danae A Delivanis; Robert P Sutcliffe; Ioanna Tsirou; Tomasz Bednarczuk; Martin Reincke; Stephanie Burger-Stritt; Richard A Feelders; Letizia Canu; Harm R Haak; Graeme Eisenhofer; M Conall Dennedy; Grethe A Ueland; Miomira Ivovic; Antoine Tabarin; Massimo Terzolo; Marcus Quinkler; Darko Kastelan; Martin Fassnacht; Felix Beuschlein; Urszula Ambroziak; Dimitra A Vassiliadi; Michael W O'Reilly; William F Young; Michael Biehl; Jonathan J Deeks; Wiebke Arlt
Journal:  Lancet Diabetes Endocrinol       Date:  2020-07-23       Impact factor: 32.069

Review 8.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

Review 9.  Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis.

Authors:  Nguyen Hoang Anh; Nguyen Phuoc Long; Sun Jo Kim; Jung Eun Min; Sang Jun Yoon; Hyung Min Kim; Eugine Yang; Eun Sook Hwang; Jeong Hill Park; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolites       Date:  2019-09-21

10.  Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.

Authors:  Vasileios Chortis; Irina Bancos; Thomas Nijman; Lorna C Gilligan; Angela E Taylor; Cristina L Ronchi; Michael W O'Reilly; Jochen Schreiner; Miriam Asia; Anna Riester; Paola Perotti; Rosella Libé; Marcus Quinkler; Letizia Canu; Isabel Paiva; Maria J Bugalho; Darko Kastelan; M Conall Dennedy; Mark Sherlock; Urszula Ambroziak; Dimitra Vassiliadi; Jerome Bertherat; Felix Beuschlein; Martin Fassnacht; Jonathan J Deeks; Michael Biehl; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.